| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Ventyx Biosciences, Inc. (VTYX) has 6 insiders with recent SEC Form 4 filings, including 2 buys and 0 sells. VTYX is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 2.37M | $18.32M | - | |
| Other | 489.5K | $3.78M | - | |
| Other | 6.0K | $6.2K | - | |
| VP | 5.3K | $5.5K | - | |
| Dir | 0 | - | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct 25, 2021 | Venbio Global Strategic Fund Iii, L.P. | 10% Owner, See Remarks | Buy | 312,500 | $16.00 | $5,000,000.00 | +8.5% | -21.0% | +50.6% | |
| Oct 25, 2021 | Royston Aaron | Director, 10% Owner | Buy | 312,500 | $16.00 | $5,000,000.00 | +8.5% | -21.0% | +50.6% |